Skip Navigation

European Heart Journal 2002 23(13):1011-1020; doi:10.1053/euhj.2001.2969
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Otterstad, J.E.
Right arrow Articles by Hall, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otterstad, J.E.
Right arrow Articles by Hall, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2–7 days) and changes at 3 months in patients with a preserved systolic function

J.E. Otterstada,f1, M.G. St. John Suttonb, G.S. Froelanda, I. Holmec, T. Skjærped and C. Halle

a Division of Cardiology, Vestfold Central Hospital, Toensberg, Norway
b Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, U.S.A.
c Institute of Medical Statistics, Ullevål Hospital, Oslo, Norway
d Division of Cardiology, University Hospital of Trondheim, Norway
e Research Institute for Internal Medicine, University of Oslo, Norway

revised August 20, 2001; accepted August 22, 2001

Abstract

Aims The purpose of this prospective, observational study was to evaluate the relationship of left ventricular volumes, systolic function and plasma N-terminal proatrial natriuretic peptide (Nt-proANP) to cardiac morbidity and mortality in post-myocardial infarction patients with left ventricular ejection fraction ≥40%.

Methods and Results Two-dimensional echocardiographic recordings and Nt-proANP measurements were obtained in 834 patients who survived acute myocardial infarction. Patients were examined at 2–7 days and 3 months after the index infarction and followed up for 24 months. All measurements of left ventricular volumes, ejection fraction and Nt-proANP were performed in core laboratories. During follow-up 102 patients sustained one or more incidents of the combined primary end-point: cardiac death (n=11), recurrent infarction (n=55) or heart failure requiring hospitalization or treatment with an ACE inhibitor and a diuretic (n=52). Using Cox proportional hazards model, baseline Nt-proANP predicted these events (chi-square 25·3, P<0·0001), while baseline echo volumes and ejection fraction did not. During the subsequent 3–24 month period, 51 patients suffered a primary end-point: cardiac death (n=9), recurrent infarction (n=29), heart failure (n=21). An increase in left ventricular end-systolic volume was the strongest predictor for adverse events (chi-square 19·1, P<0·0001), especially for heart failure. Individual changes in Nt-proANP did not predict cardiac events, whereas both echocardiographic variables and Nt-proANP measured at 3 months had a prognostic impact on subsequent cardiac events (3–24 months).

Conclusions In post-myocardial infarction patients with preserved left ventricular function (left ventricular ejection fraction ≥40%) baseline Nt-proANP, but not echocardiographic left ventricular volumes predicted adverse cardiac events. Early changes in left ventricular volumes and ejection fraction from baseline to 3 months had a further prognostic impact on subsequent events (3–24 months). Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.

Key Words: Myocardial infarction, left ventricular remodelling, N-terminal proatrial natriuretic factor, two-dimensional echocardiography

f1 Correspondence: Jan Erik Otterstad, MD, FESC, Division of cardiology, Vestfold Central Hospital, N-3116 Toensberg, Norway.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
A. M. Dart, J. E. Otterstad, B.-A. Kirwan, J. D. Parker, S. de Brouwer, P. A. Poole-Wilson, and J. Lubsen
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study
Eur J Echocardiogr, August 1, 2007; 8(4): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Hole, C. Hall, and T. Skjaerpe
N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction
Eur. Heart J., March 1, 2004; 25(5): 416 - 423.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. E. Moller, B. Brendorp, M. Ottesen, L. Kober, K. Egstrup, S. H. Poulsen, and C. Torp-Pedersen
Congestive heart failure with preserved left ventricular systolic function after acute myocardial infarction: clinical and prognostic implications
Eur J Heart Fail, December 1, 2003; 5(6): 811 - 819.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. J. O'Brien, I. B. Squire, B. Demme, J. E. Davies, and L. L. Ng
Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF
Eur J Heart Fail, August 1, 2003; 5(4): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J E Otterstad
Measuring left ventricular volume and ejection fraction with the biplane Simpson's method
Heart, December 1, 2002; 88(6): 559 - 560.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F.J. Pinto
Echocardiography or Nt-proANP in post-myocardial infarction patients: is one enough?
Eur. Heart J., July 1, 2002; 23(13): 996 - 997.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.